The NHS’ next chapter – managed decline, or new opportunities for pharma?
I’ve been thinking about the next stage of the NHS. What it will look like, how it should be funded, what it should be doing, and even if it has a future at all.
If that last one sounds dramatic, blame Chris Ham of the King’s Fund; his excellent paper Rise and Decline of the NHS 2000-2023, was a stark reminder that what NHS commentators write about these days in terms of a huge crisis was not always the case.
Between 2000-2010, the NHS improved in many ways. Funding increases went way above the tracking norm. Capital budgets increased allowing the service to invest in new premises and equipment, while staff became better paid and motivated.
Check out the rest of this feature here
Source link
#Borrowed #time #PharmaTimes
